Enhanced fluorescent detection of oxaliplatin <i>via</i> BSA@copper nanoclusters: a targeted approach for cancer drug monitoring

Alqahtani, Yahya S.; Mahmoud, Ashraf M.; Ibrahim, Hossieny; El-Wekil, Mohamed M.

doi:10.1039/d4ay00355a

Anal. Methods

2024

DOI: 10.1039/d4ay00355a

|View full text |Cite

Enhanced fluorescent detection of oxaliplatin via BSA@copper nanoclusters: a targeted approach for cancer drug monitoring

Yahya S. Alqahtani,

Ashraf M. Mahmoud,

Hossieny Ibrahim

et al.

Abstract: A new BSA@CuNC fluorescent probe was designed for selective and sensitive detection of Oxal-Pt. Addition of Oxal-Pt led to fluorescence enhancement through aggregation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Copper-Based Nanomaterials for Image-Guided Cancer Therapy

Xu,

Guo,

et al. 2024

BIOI

View full text Add to dashboard Cite

Cancer is a significant disease that poses a major threat to human health. Image-guided cancer therapy refers to a series of medical procedures that use imaging technology to precisely locate and treat cancer. Combining the dual characteristics of medical images and functional nanomaterial (NM) drug carriers, various integrated diagnosis and treatment probes have been developed for in vivo dynamic monitoring and therapeutic effect evaluation of drugs based on medical imaging. Copper (Cu)-based NMs have emerged as valuable products of nanotechnology due to their unique physicochemical properties, which are influenced by factors, such as size, shape, and surface properties. In the field of imaging, Cu-based NMs offer a combination of desirable characteristics, including fluorescence emission, contrast enhancement, and radiolabeling stability. These properties form the foundation for a wide range of imaging modalities. In addition, Cu-based NMs can be used as a carrier for diagnostic or therapeutic drugs and the synergistic effect of multiple therapeutic modalities can be realized by doping multiple transition metals into the heterostructures. These properties have become an important basis for imaging-guided therapy with Cu-based NMs. In this review we introduce biocompatible Cu-based NMs for image-guided cancer therapy and provide an overview of the promising outcomes in biomedical research.

show abstract

Copper-Based Nanomaterials for Image-Guided Cancer Therapy

Xu,

Guo,

et al. 2024

BIOI

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Enhanced fluorescent detection of oxaliplatin via BSA@copper nanoclusters: a targeted approach for cancer drug monitoring

Abstract: A new BSA@CuNC fluorescent probe was designed for selective and sensitive detection of Oxal-Pt. Addition of Oxal-Pt led to fluorescence enhancement through aggregation.

Cited by 1 publication

References 44 publications

Copper-Based Nanomaterials for Image-Guided Cancer Therapy

Copper-Based Nanomaterials for Image-Guided Cancer Therapy

Contact Info

Product

Resources

About